IMU 3.39% 5.7¢ imugene limited

Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-201

  1. 313 Posts.
    lightbulb Created with Sketch. 48
    the cost to BP for the provision of these drugs for trials is negligible to them. They are basically saying to Imugene "make our inferior product work & then we may talk". The mere association with them creates a bit of excitement. Realistically, nothing has changed yet, & the market, to date seems to agree. The positive is the pathway it creates, if successful.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.7¢
Change
-0.002(3.39%)
Mkt cap ! $418.9M
Open High Low Value Volume
6.0¢ 6.2¢ 5.6¢ $1.863M 31.44M

Buyers (Bids)

No. Vol. Price($)
3 214965 5.7¢
 

Sellers (Offers)

Price($) Vol. No.
5.8¢ 60000 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.